The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
Keyword(s):
Keyword(s):
2019 ◽
Vol 43
(4)
◽
pp. 628-633
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):